The Indian multinational pharmaceutical company, Cipla, is a well-known name in the healthcare industry. The company has been making waves in the stock market, with analysts predicting a bright future for Cipla’s share price target in the next few years.
With a focus on innovation and providing affordable healthcare solutions, many investors are considering Cipla as a good auto stock to buy. One such example of Cipla’s innovative spirit is its recent launch of a point-of-care testing device, which has the potential to revolutionize the way people receive medical tests.
This article will explore the potential of Cipla’s share price target from 2023 to 2030, examining the factors that could impact its growth and making predictions for the future.
Stock history of Cipla
Cipla’s stock history reflects its growth and success in the industry, with the company’s share price reaching new heights over time. In the early days, Cipla was primarily focused on producing generic drugs and supplying them to the Indian market. As the company expanded its offerings and reached new markets, its stock price grew steadily.
In the late 1990s and early 2000s, Cipla made a significant push into international markets, establishing a strong presence in Africa and other developing countries. This growth was reflected in the company’s stock price, which rose steadily over the next decade.
More recently, Cipla has continued to focus on innovation and growth. In 2020, the company launched its point-of-care testing device, a cutting-edge solution that has the potential to greatly improve the way people receive medical tests. This move is expected to drive further growth for Cipla and boost its share price in the coming years.
Currently, the stocks of Cipla are trading at Rs. 1,021.15.
Latest news about Cipla
- In the past year, 8.9% of Cipla Limited (NSE:CIPLA) insider’s holdings were sold.
- Cipla has introduced a new device for point-of-care testing.
- Domestic Brokerage Motilal Oswal Assigns Neutral Rating to Company Stock with Concerns over Regulatory Risks and Weak Quarterly Performance
How to buy Cipla shares?
You can buy Cipla shares from the following trading platforms:
➤ Zerodha
➤ Upstox
➤ Groww
➤ AngelOne
➤ ICICIDirect
Share Price Prediction of Cipla: 2023 to 2030
Share Price Target 2023 of Cipla
| When | Maximum Price | Minimum Price |
| February 2023 | ₹1,039.00 | ₹799.23 |
| March 2023 | ₹899.25 | ₹799.42 |
| April 2023 | ₹877.18 | ₹759.37 |
| May 2023 | ₹814.31 | ₹749.47 |
| June 2023 | ₹857.18 | ₹759.37 |
| July 2023 | ₹1,028.61 | ₹791.24 |
| August 2023 | ₹1,131.47 | ₹870.36 |
| September 2023 | ₹1,188.04 | ₹913.88 |
| October 2023 | ₹1,131.47 | ₹870.36 |
| November 2023 | ₹1,244.62 | ₹957.40 |
| December 2023 | ₹1,393.97 | ₹1,072.29 |
The share price of Cipla is expected to experience significant growth in 2023, with predictions ranging from a minimum of ₹799.42 to a maximum of ₹1399.97. This bullish uptrend is expected to continue throughout the year, with the company’s share price showing consistent growth in both the first and second halves of 2023.
The highest predicted growth for Cipla share is expected in August 2023, with a predicted maximum price of ₹1,131.47, while the lowest minimum price is expected in May 2023, at ₹749.47.
Cipla’s share price is expected to grow by an average of 20-25% in 2023, making it a promising investment opportunity for those looking to invest in the healthcare sector.
Cipla Share Price Target 2024
| When | Maximum Price | Minimum Price |
| January 2024 | ₹1,467.34 | ₹1,128.72 |
| February 2024 | ₹1,648.70 | ₹1,373.91 |
| March 2024 | ₹1,735.47 | ₹1,410.95 |
| April 2024 | ₹1,577.70 | ₹1,213.61 |
| May 2024 | ₹1,314.75 | ₹1,011.35 |
| June 2024 | ₹1,577.70 | ₹1,213.61 |
| July 2024 | ₹1,341.04 | ₹1,039.57 |
| August 2024 | ₹1,475.15 | ₹1,170.75 |
| September 2024 | ₹1,548.91 | ₹1,191.47 |
| October 2024 | ₹1,822.24 | ₹1,401.73 |
| November 2024 | ₹1,913.35 | ₹1,471.81 |
| December 2024 | ₹1,951.62 | ₹1,501.25 |
The share price of Cipla is expected to continue its growth trend in 2024, with predictions ranging from a minimum of ₹1,011.35 to a maximum of ₹1,951.62. The highest predicted growth is expected in October 2024, with a predicted maximum price of ₹1,822.24, while the lowest minimum price is expected in May 2024, at ₹1,314.75.
This bullish uptrend is expected to persist throughout the year, with the company’s share price showing consistent growth in both the first and second halves of 2024.
The minimum and maximum share price targets for 2024 are ₹1,011.35 and ₹1,951.62, respectively.
Share Price Target 2025 of Cipla
| When | Maximum Price | Minimum Price |
| January 2025 | ₹1,990.65 | ₹1,531.27 |
| February 2025 | ₹2,095.43 | ₹1,611.87 |
| March 2025 | ₹2,200.20 | ₹1,692.46 |
| April 2025 | ₹1,964.46 | ₹1,511.12 |
| May 2025 | ₹1,785.87 | ₹1,373.75 |
| June 2025 | ₹1,964.46 | ₹1,511.12 |
| July 2025 | ₹1,870.92 | ₹1,439.17 |
| August 2025 | ₹1,948.87 | ₹1,499.13 |
| September 2025 | ₹2,046.31 | ₹1,574.09 |
| October 2025 | ₹2,169.09 | ₹1,668.53 |
| November 2025 | ₹2,320.93 | ₹1,785.33 |
| December 2025 | ₹2,367.35 | ₹1,821.04 |
Like 2023 and 2024, Cipla share price is predicted to continue its positive movement in 2025, with predictions ranging from a minimum of ₹1,373.75 to a maximum of ₹2,367.35.
The highest predicted growth is expected in November 2025, with a predicted maximum price of ₹2,320.93, while the lowest minimum price is expected in May 2025, at ₹1,785.87.
This bullish uptrend is expected to persist throughout the year, with the company’s share price showing consistent growth in both the first and second halves of 2025.
Cipla Share Price Prediction 2026-2030
| Year | Maximum Price | Minimum Price |
| 2026 | ₹1,657.14 | ₹1,160.00 |
| 2027 | ₹1,408.57 | ₹986.00 |
| 2028 | ₹2,535.43 | ₹1,774.80 |
| 2029 | ₹5,208.17 | ₹3,645.72 |
| 2030 | ₹5,800.00 | ₹4,060.00 |
The Cipla share price target from 2026 to 2030 showcases a bullish trend with a significant growth percentage. In 2026, the maximum price for Cipla shares is expected to reach ₹1,657.14 with a minimum price of ₹1,160.00.
The year 2027 and 2028 see a moderate dip in the share price with the maximum price being ₹1,408.57 and ₹2,535.43 respectively.
However, from 2029 onwards, the share price experiences an upward trend with a maximum price of ₹5,208.17 in 2029 and ₹5,800.00 in 2030, which is a substantial increase from the previous years.
Cipla share price target from 2026 to 2030 suggests a positive outlook with a bullish trend and an uptrend in the future.
Financial Condition of Cipla: Last 5 years
| Narration | Mar-18 | Mar-19 | Mar-20 | Mar-21 | Mar-22 |
| Sales | 15,155.71 | 16,362.41 | 17,131.99 | 19,159.59 | 21,763.34 |
| Expenses | 12,329.33 | 13,265.10 | 13,926.00 | 14,907.16 | 17,210.56 |
| Operating Profit | 2,826.38 | 3,097.31 | 3,205.99 | 4,252.43 | 4,552.78 |
| Other Income | 280.13 | 476.57 | 344.20 | 265.99 | 98.79 |
| Depreciation | 1,322.82 | 1,326.31 | 1,174.65 | 1,067.66 | 1,051.95 |
| Interest | 114.23 | 168.43 | 197.36 | 160.70 | 106.35 |
| Profit before tax | 1,669.46 | 2,079.14 | 2,178.18 | 3,290.06 | 3,493.27 |
| Tax | 250.11 | 569.53 | 631.20 | 888.76 | 933.80 |
| Net profit | 1,410.53 | 1,527.70 | 1,546.52 | 2,404.87 | 2,516.75 |
| EPS | 17.52 | 18.96 | 19.18 | 29.82 | 31.19 |
| Price to earning | 31.13 | 27.89 | 22.04 | 27.34 | 32.64 |
| Price | 545.45 | 528.90 | 422.85 | 815.10 | 1,018.05 |
| RATIOS: | |||||
| Dividend Payout | 17.12% | 15.82% | 20.85% | 16.77% | 16.03% |
| OPM | 18.65% | 18.93% | 18.71% | 22.19% | 20.92% |
Cipla’s financial statement of the past five years reflects the company’s growth in terms of profit and loss. The sales revenue has increased from ₹15,155.71 in March 2018 to ₹21,763.34 in March 2022, with a percentage growth of 43.6%. On the other hand, the expenses have increased from ₹12,329.33 to ₹17,210.56, leading to a decline in the operating profit margin from 18.65% to 20.92%.
However, the net profit after tax (PAT) has consistently increased, reaching its maximum of ₹2,516.75 in March 2022. The earnings per share (EPS) have also increased from 17.52 to 31.19.
The price-to-earnings ratio (P/E) has fluctuated from a minimum of 22.04 to a maximum of 32.64. The company has shown a steady growth in revenue and profit, which is reflected in its PAT and EPS.
The dividend payout has also increased from 17.12% in March 2018 to 16.03% in March 2022.
Cipla share price target by Experts
Cipla share price target by Axis Securities
Axis Securities is recommending investors to purchase Cipla NSE stocks, with a target price of Rs 1230.
Credit Suisse has lowered its target for Cipla’s share price from Rs 1,300 to Rs 1,050.
Cipla share price target by Jefferies
Jefferies has downgraded its rating on Cipla’s stock to “Hold” and also decreased its share price target for the company from Rs 1,100 to Rs 900.
Cipla share price target by JPMorgan
JPMorgan, who had an “Overweight” rating on Cipla’s shares, has lowered their share price target for the company from Rs 1,210 to Rs 1,030.
Cipla share price target by Nomura
Nomura has recommended a “Buy” for Cipla’s shares, but they have also decreased their share price target for the company from Rs 1,195 to Rs 1,036.
Cipla share price target by Motilal Oswal
Motilal Oswal, one of the leading domestic brokerage has assigned a Neutral rating to the stock of the company, while setting a price target of Rs 990. The firm has expressed concerns regarding the heightened regulatory risks and weak quarterly performance of the company in recent times.
Average Cipla share price target of several analysts is 1080 INR.
FAQS
Will the share price of Cipla increase in 2023?
It is anticipated that Cipla per share price will increase to ₹1,394 by the end of 2023.
Is it a good time to buy Cipla?
Investors can expect Cipla’s share price to grow in the coming years, making it a solid investment opportunity for those looking to invest in the healthcare sector.
What is the share price target Cipla for 2030?
The share price target of Cipla for 2030 might be around ₹5,800. With a continued focus on innovation, affordable healthcare solutions, and expanding into new markets, Cipla is well-positioned for continued success in the coming years.
Can CIPLA touch 5000 INR by 2030?
According to out Cipla share price prediction, CIPLA can reach Rs.5000 by 2030. The maximum it could reach in 2030 is ₹5,800.00.
What is the share price target Cipla for 2025?
The maximum Cipla share price target for 2025 is ₹2,367.35 which is expected to be reached by December 2025. It represents a potential increase of over 168% from the current price of ₹881 as of March 12, 2023. On the other hand, the minimum share price target of Cipla for 2025 is ₹1,373.75 which is expected to reach in May 2025 which would still represent a substantial increase of over 56% from the current price.
Also read:
- Online Casino Gaming Tips.
- What is a stablecoin? Types, Use cases and Best Stablecoins in 2023.
- Top Side Hustles To Make Money From Your Love For Soccer.
Conclusion: Should You Buy CIPLA in 2023?
Based on the analysis of Cipla’s financial performance over the last five years, it is clear that the company has experienced significant growth in terms of revenue, profit and overall financial performance.
With a consistent increase in sales and a significant growth in PAT, Cipla has shown its ability to generate positive results year after year.
The company’s impressive revenue growth and profit growth are promising indicators of its future performance. Additionally, the company’s increasing dividend payouts and growing price to earning ratio suggest that Cipla’s shares are good to buy.
I like CIPLA more than any other pharma stocks. I personally have been holding Lupin and do not hold any Cipla shares but this is a regret. I will be switching to Cipla once (and if) it corrects to 750 levels. Cipla is one of those pharma companies which has been posting great numbers in terms of revenue and profits, continuously. And in my opinion, it is a better hold, as I expect CIPLA to keep posting great results in future.
In conclusion, with a promising future outlook, Cipla’s share price target from 2023 to 2030 looks positive and holds potential for good returns for investors.
